Commands a premium valuation multiple over its peers, likely pricing in superior execution.
Moderate quality score of 53/100, reflecting stable operating margins and manageable leverage.
Analysts remain bullish, forecasting further upside expansion with consensus targets suggesting solid gains.
Confirm your valuation thesis with live pattern overlays, key pivot levels, and AI trade plans.
Verdict: Average quality business weighed down by significant profitability concerns.
Wall Street is highly bullish, projecting significant upside. The company currently dilutes shareholders to fund operations and growth rather than returning capital.
CVNA demonstrates adequate business quality with stable profitability. This is paired with a moderately leveraged but stable balance sheet.
The company demonstrates solid revenue growth (14.3% 3Y CAGR) paired with stable bottom-line earnings. Operating efficiency remains adequate with margins around 8.9%.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $7.4B | +48.6% | +14.3% | +29.5% | +65.7% | |
| EBITDA | $749.0M | — | — | — | — | |
| Net Income | $310.0M | +570.0% | — | — | — | |
| EPS (Diluted) | $0.42 | +431.4% | — | — | — | |
| Free Cash Flow | $187.0M | +7.5% | — | — | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 19.4% | 18.8% | 15.6% | 12.2% |
| Operating Margin | 8.9% | 5.3% | 0.8% | -6.3% |
| Net Margin | 6.3% | 4.2% | -0.0% | -1.4% |
| FCF Margin | 3.7% | 5.7% | -4.2% | -20.1% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q3'26Latest | $0.39 | $0.42 | +8.6% | ||
| Q2'26 | $0.32 | $0.34 | +7.4% | ||
| Q1'26 | $0.23 | $0.84 | +265.2% | ||
| Q4'25 | $0.27 | $0.21 | -22.2% | ||
| Q3'25 | $0.23 | $0.26 | +11.4% | ||
| Q2'25 | $0.73 | $0.30 | -59.1% | ||
| Q1'25 | $0.29 | $0.11 | -61.9% | ||
| Q4'24 | $0.23 | $0.13 | -43.5% |
Total return is -15.4% (1Y), lagging the benchmark by -31.2%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -20.1% | -32.5% | — |
| 1Y | -15.4% | -31.2% | — |
| 3YCAGR | +99.5% | +77.0% | — |
| 5YCAGR | +0.0% | -11.3% | — |
| 10YCAGR | +39.9% | +26.7% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Carvana Co. (CVNA) valuation, health, and returns.
Carvana Co. is estimated to be fair under our discounted cash flow framework. relative multiples indicate the stock is Expensive versus peers compared to industry peers. trading near fair value (DCF: $62.19)
Carvana Co. has multiple valuation anchors: DCF Intrinsic Value: $62.19 | Peer Relative Fair Value: $26.67 | Wall Street Analyst Target: $84.55 (implying +32.2% upside). A convergence of these signals offers higher conviction.
Carvana Co. displays fair financial health with a composite quality score of 53/100, supported by a Altman Z-Score of 6.8 (safe zone), Piotroski F-Score of 6/9, Return on Invested Capital (ROIC) of 21.5%.
Carvana Co. does not return material capital to shareholders via dividends or share repurchases, electing to retain earnings to fund internal growth.
Carvana Co.'s current growth trajectory is Accelerating. The company achieved +48.6% 1Y revenue growth and +431.4% 1Y EPS growth, compared to its 3Y revenue CAGR of +14.3%.
Wall Street consensus is Hold based on 46 analysts, beating EPS expectations in 67% of recent quarters with a 3-quarter streak. The consensus price target represents a +32.2% change from current levels.
Investment risks for Carvana Co. include: -41.2% 1-year max drawdown, high beta (2.32x market volatility). Volatility risk is characterized by a beta of 2.32x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.